Clinical trials
Attention Deficit Disorder with Hyperactivity trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 17 |
| Recruiting | 10 |
| Not yet recruiting | 4 |
| Terminated | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 10 |
| Hospices Civils de Lyon | 7 |
| University Hospital, Strasbourg, France | 7 |
| Shire | 5 |
| University Hospital, Bordeaux | 5 |
| University Hospital, Montpellier | 4 |
| Eli Lilly and Company | 3 |
| Fondation Lenval | 3 |
| Nantes University Hospital | 3 |
| University Hospital, Caen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 79 |
| Spasm | 5 |
| Autism Spectrum Disorder | 4 |
| Substance-Related Disorders | 3 |
| Anxiety Disorders | 2 |
| Epilepsy | 2 |
| Neurodevelopmental Disorders | 2 |
| Sleep Wake Disorders | 2 |
| Sleepiness | 2 |
| Alcoholism | 1 |
Trials
Showing 26 to 50 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.